← Back to Clinical Trials
Recruiting NCT06636474

NCT06636474 Evaluation of the Supported Housing System for the Inclusion of People Suffering From Mental Disorders

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06636474
Status Recruiting
Phase —
Sponsor Centre Hospitalier St Anne
Condition Mental Disorder
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2020-07-27
Primary Completion 2030-07-27

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
patients with mental disorders

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2020-07-27 with a primary completion date of 2030-07-27.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Access to housing, in the current context of extreme tension in the rental housing market in Paris and throughout the Ile-de-France region, is proving to be extremely complex for people with mental health problems.National and international scientific studies have quantified the problem of homelessness and precarious or inappropriate housing among patients suffering from psychiatric disorders, and show the impact of housing problems on the consumption of psychiatric care.The DÉLAI's mission is to facilitate access to housing for people enrolled in a psychiatric care pathway, with teams from the psychiatric sectors

Eligibility Criteria

Inclusion Criteria: patient followed for a psychiatric disorder patient benefiting from a DLAI Exclusion Criteria: patient not followed for psychiatric disorder patient who refused to participate in the research

Contact & Investigator

Central Contact

Alexandra PHAM-scottez, Pr

✉ a.pham@ghu-paris.fr

📞 + 33 (0)1 45 65 83 70 / 81 08

Frequently Asked Questions

Who can join the NCT06636474 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Mental Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06636474 currently recruiting?

Yes, NCT06636474 is actively recruiting participants. Contact the research team at a.pham@ghu-paris.fr for enrollment information.

Where is the NCT06636474 trial being conducted?

This trial is being conducted at Paris, France.

Who is sponsoring the NCT06636474 clinical trial?

NCT06636474 is sponsored by Centre Hospitalier St Anne. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology